Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Huys

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Orphanet Journal of Rare Diseases|July 2, 2025
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultationsZilke Claessens, Alice Vanneste, Charlotte Van Isterdael, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 21, 2017
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and RheumatologistsEline van Overbeeke, Birgit De Beleyr, Jan de Hoon, et al.
Journal of Pharmaceutical Policy and Practice|June 23, 2021
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physiciansLiese Barbier, Yannick Vandenplas, Steven Simoens, et al.
Journal of Market Access & Health Policy|April 24, 2026
When Do Annuity-Based Payments Help to Address the Affordability Challenge of Funding Advanced Therapies? Insights from a Budget Impact SimulationWalter Van Dyck, Sissel Michelsen, David Veredas, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 9, 2015
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in BelgiumTiene Bauters, Barbara Om Claus, Koen Norga, et al.
Frontiers in Pharmacology|June 24, 2017
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial LandscapeEvelien Moorkens, Nicolas Meuwissen, Isabelle Huys, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2025
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative StudyElif Car, Liese Barbier, Ingrid Schwarzenberger, et al.
British Journal of Cancer|July 2, 2019
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilarsLiese Barbier, Paul Declerck, Steven Simoens, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 18, 2022
Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across EuropeTeresa Barcina Lacosta, Arnold G Vulto, Adina Turcu-Stiolica, et al.
Frontiers in Medicine|March 31, 2022
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice MessagingLiese Barbier, Allary Mbuaki, Steven Simoens, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Orphanet Journal of Rare Diseases|July 2, 2025
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultationsZilke Claessens, Alice Vanneste, Charlotte Van Isterdael, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 21, 2017
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and RheumatologistsEline van Overbeeke, Birgit De Beleyr, Jan de Hoon, et al.
Journal of Pharmaceutical Policy and Practice|June 23, 2021
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physiciansLiese Barbier, Yannick Vandenplas, Steven Simoens, et al.
Journal of Market Access & Health Policy|April 24, 2026
When Do Annuity-Based Payments Help to Address the Affordability Challenge of Funding Advanced Therapies? Insights from a Budget Impact SimulationWalter Van Dyck, Sissel Michelsen, David Veredas, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 9, 2015
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in BelgiumTiene Bauters, Barbara Om Claus, Koen Norga, et al.
Frontiers in Pharmacology|June 24, 2017
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial LandscapeEvelien Moorkens, Nicolas Meuwissen, Isabelle Huys, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2025
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative StudyElif Car, Liese Barbier, Ingrid Schwarzenberger, et al.
British Journal of Cancer|July 2, 2019
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilarsLiese Barbier, Paul Declerck, Steven Simoens, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 18, 2022
Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across EuropeTeresa Barcina Lacosta, Arnold G Vulto, Adina Turcu-Stiolica, et al.
Frontiers in Medicine|March 31, 2022
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice MessagingLiese Barbier, Allary Mbuaki, Steven Simoens, et al.
Pageof 21